Home Applications 209229 Application 209229
Type NDA
Sponsor US WORLDMEDS LLC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LUCEMYRA LOFEXIDINE HYDROCHLORIDE TABLET;ORAL EQ 0.18MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209229-001 LUCEMYRA LOFEXIDINE HYDROCHLORIDE EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N209229-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL AB RLD, RS 2018-05-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N209229-001 LUCEMYRA EQ 0.18MG BASE TABLET / ORAL RLD, RS 2018-05-16 cb3db0bc1861…
Observed Orange Book normalized TE history# Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 8 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 27505-050 Lucemyra lofexidine hydrochloride US WorldMeds, LLC NDA Current 27505-050 Lucemyra lofexidine hydrochloride US WorldMeds, LLC NDA Current 27505-050 Lucemyra lofexidine hydrochloride US WorldMeds, LLC NDA Current 27505-050 Lucemyra lofexidine hydrochloride US WorldMeds, LLC NDA Current 78670-050 Lucemyra lofexidine hydrochloride USWM, LLC NDA Current 78670-050 Lucemyra lofexidine hydrochloride USWM, LLC NDA Current 78670-050 Lucemyra lofexidine hydrochloride USWM, LLC NDA Current 78670-050 Lucemyra lofexidine hydrochloride USWM, LLC NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 79557 SUPPL 2024-09-06 79556 SUPPL 2024-09-06 54725 ORIG 2018-06-28 54220 ORIG 2018-05-16 54219 ORIG 2018-05-16